Following the directions of Delhi Health and Family Welfare Minister Pankaj Kumar Singh, the Delhi Drugs Control Department conducted a special enforcement drive at a wholesale drug market in Delhi to ensure the availability of safe, effective and quality medicines to the public, particul
The DCGI (Drugs Controller General of India) on Wednesday issued an alert regarding a stolen batch of Sanofi India's insulin formulation, Lantus SoloStar (Insulin Glargine Injection IP, r-DNA origin, 100 IU/mL), with batch number 5F0347B.
Telangana Drugs Control Administration (DCA) raided a clinic operated by an unqualified practitioner at Shayampet village in Hanumakonda district and seized medicines illegally stocked for sale.
Drugs Control Administration, Telangana, busted the unlicensed manufacturing and sale/distribution of medical devices at Bluesemi Research and Development Pvt. Ltd., Raidurg, Serilingampally, Ranga Reddy district. Stocks worth Rs 4 lakhs were seized during the raid, a Drug Control officia
Stepping up its crackdown on the illegal drug trade, the Drugs Control Department of the Government of NCT of Delhi conducted a special inspection and enforcement drive at Bhagirath Palace.
The petition was filed by the Gautam Gambhir Foundation, Gautam Gambhir, his mother Seema Gambhir, and his wife Natasha Gambhir, seeking the quashing of the complaint lodged by the Drugs Control Department of the Delhi Government and the subsequent summons issued on August 26, 2021.
As this happened, Tamil Nadu Drugs Control Department on Monday announced the cancellation of the manufacturing license of Sresan Pharmaceutical company, the manufacturer of Coldrif cough syrup, linked with deaths of at least 22 people in Madhya Pradesh.
Tamil Nadu Drugs Control Department on Monday announced the cancellation of the manufacturing license of Sresan Pharmaceutical company, the manufacturer of Coldrif cough syrup, linked with deaths of at least 22 people in Madhya Pradesh.
BJP leader K. Annamalai has criticised the Tamil Nadu government for its handling of a case involving a private pharmaceutical company in Kanchipuram, allegedly linked to the deaths of 23 people in Madhya Pradesh and three children in Rajasthan due to a faulty drug.
In a letter dated October 7, the Drugs Controller General of India (DCGI) Dr Rajeev Singh Raghuvanshi emphasised the "critical importance of testing new materials, including the excipients, before their use in the manufacturing of pharmaceutical formulations."
Health Minister Veena George announced that all medicines manufactured by Sresan Pharmaceuticals, a company based in Kanchipuram, Tamil Nadu, have been banned from distribution and sale in Kerala. The move follows action taken by the Tamil Nadu Drugs Controller to cancel the company's man